INGN Inogen Inc

Price (delayed)

$51.59

Market cap

$1.14B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.09

Enterprise value

$937.53M

Sector: Healthcare
Industry: Medical Devices

Highlights

The equity rose by 2.7% year-on-year
Inogen's net income has plunged by 132% from the previous quarter and by 106% YoY
Inogen's EPS has plunged by 130% from the previous quarter and by 106% YoY

Key stats

What are the main financial stats of INGN
Market
Shares outstanding
22.12M
Market cap
$1.14B
Enterprise value
$937.53M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.23
Price to sales (P/S)
3.62
EV/EBIT
N/A
EV/EBITDA
67.16
EV/Sales
2.99
Earnings
Revenue
$313.43M
EBIT
-$4.31M
EBITDA
$13.96M
Free cash flow
$16.4M
Per share
EPS
-$0.09
Free cash flow per share
$0.75
Book value per share
$15.97
Revenue per share
$14.25
TBVPS
$16.2
Balance sheet
Total assets
$460.33M
Total liabilities
$107.83M
Debt
$10.46M
Equity
$352.5M
Working capital
$251.41M
Liquidity
Debt to equity
0.03
Current ratio
5.84
Quick ratio
4.85
Net debt/EBITDA
-14.58
Margins
EBITDA margin
4.5%
Gross margin
44%
Net margin
-0.7%
Operating margin
-3.8%
Efficiency
Return on assets
-0.5%
Return on equity
-0.6%
Return on invested capital
-4.4%
Return on capital employed
-1.1%
Return on sales
-1.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INGN stock price

How has the Inogen stock price performed over time
Intraday
2.32%
1 week
-3.77%
1 month
9.95%
1 year
18.76%
YTD
15.47%
QTD
15.47%

Financial performance

How have Inogen's revenue and profit performed over time
Revenue
$313.43M
Gross profit
$138.04M
Operating income
-$11.82M
Net income
-$2.08M
Gross margin
44%
Net margin
-0.7%
The operating margin has plunged by 147% YoY
INGN's operating income has dropped by 140% year-on-year
The net margin has dropped by 135% since the previous quarter and by 108% year-on-year
Inogen's net income has plunged by 132% from the previous quarter and by 106% YoY

Growth

What is Inogen's growth rate over time

Valuation

What is Inogen stock price valuation
P/E
N/A
P/B
3.23
P/S
3.62
EV/EBIT
N/A
EV/EBITDA
67.16
EV/Sales
2.99
Inogen's EPS has plunged by 130% from the previous quarter and by 106% YoY
INGN's P/B is 57% below its 5-year quarterly average of 7.5 but 11% above its last 4 quarters average of 2.9
The equity rose by 2.7% year-on-year
The stock's price to sales (P/S) is 46% less than its 5-year quarterly average of 6.7 but 25% more than its last 4 quarters average of 2.9
The revenue has declined by 15% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Inogen business performance
Inogen's ROS has plunged by 174% from the previous quarter and by 115% YoY
INGN's ROIC has plunged by 173% from the previous quarter and by 118% YoY
Inogen's ROA has plunged by 136% from the previous quarter and by 106% YoY
Inogen's return on equity has shrunk by 132% QoQ and by 106% YoY

Dividends

What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INGN.

Financial health

How did Inogen financials performed over time
The debt is 97% smaller than the equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.